Patents
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
04/2009
04/07/2009US7514558 e.g. 3-(4-{[6-({(2R)-2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl)-phenyl]ethyl}amino)-hexyl]oxy}butyl)benzenesulfonamide; beta 2 adrenergic receptor agonist and muscarinic receptor antagonist activity; bronchodilator agent; pulmonary disorders: chronic obstructive pulmonary disease; asthma
04/07/2009US7514555 Compounds for the treatment of metabolic disorders
04/07/2009US7514455 Derivatives of 2-pyridinol or its tautomer 2-pyridone; microorganism comprising Penicillium sp. FO-125 FERM BP-8048; antifungal antibiotics
04/07/2009US7514454 Piperidin-2,6-dione pamoate salts and their use for the treatment of stress-related affective disorders
04/07/2009US7514453 Method for enhancing mutant protein activity
04/07/2009US7514431 Piperidinyl cyclopentyl aryl benzylamide modulators of chemokine receptor activity
04/07/2009US7513918 Agents for coloring keratin fibers comprising zwitterionic azomethine dyes
04/07/2009CA2511255C 2-piperidone derivatives as prostaglandin agonists
04/07/2009CA2453382C Mannitol and glucitol derivatives
04/07/2009CA2450858C Novel crystalline forms of 4-[4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-1-hydroxybutyl]-.alpha.,.alpha.-dimethylbenzene acetic acid and its hydrochloride
04/07/2009CA2407345C 4-benzyl-1-[2-(4-hydroxy-phenoxy)-ethyl]-piperidine-3,4-diol
04/07/2009CA2393757C Cycloamine ccr5 receptor antagonists
04/07/2009CA2390116C Triphenylalkene derivatives and their use as selective estrogen receptor modulators
04/07/2009CA2343786C Process for the synthesis of 4-substituted n-[(alk-2- en-1-yl)oxy]- and n-aralkyloxy- 2,2,6,6-tetraalkylpiperidines
04/07/2009CA2294950C Levobupivacaine and its use
04/02/2009WO2009041567A1 Diaryl ketimine derivative having antagonistic activity on melanin-concentrating hormone receptor
04/02/2009WO2008156832A3 Renin inhibitors
04/02/2009US20090088455 Chronic, Bolus Adminstration Of D-Threo Methylphenidate
04/02/2009US20090088454 Anti-cancer compounds
04/02/2009US20090088453 such as biphenyl-2-yl-carbamic acid 1- {2-[5-(4-carbamoylpiperidin-l-ylmethyl)thiophen-2-ylcarbamoyl]ethyl}piperidin-4-yl ester for treating pulmonary disorders (asthma, chronic obstructive pulmonary disease); anticholinergic agents; reduced side effects such as dry mouth and constipation
04/02/2009US20090088414 Soluble 17-amino-analogs of geldanamycin in acid addition salt form; water solubility; anticancer agents; storage stability
04/02/2009US20090088322 e.g.4-Amino-6-(4-chlorophenyl)-5-fluoro-3-vinylpyridine-2-carboxylic acid; 4-Acetylamino-6-(4-chloro-2-fluoro-3-methoxyphenyl)-3-trimethylsilanylethynylpyridine-2-carboxylic acid methyl ester;
04/02/2009DE19959619B4 Sterisch gehinderte Aminverbindungen und damit stabilisierte organische Materialien Sterically hindered amine compounds and organic materials stabilized therewith
04/02/2009CA2697580A1 Octahydropentalene compounds as chemokine receptor antagonists
04/01/2009EP2041087A1 2 -oxybenzamide derivatives as parp inhibitors
04/01/2009EP2040698A2 Oxime compounds and the use thereof
04/01/2009CN101400653A 11-beta HSD1 inhibitors
04/01/2009CN101400652A Use of tetrahydropyridines in the treatment of central nervous system disorders
04/01/2009CN101400651A Diaryl piperidines as CB1 modulators
04/01/2009CN101400642A Tropane prodrugs with central nervous system activity
04/01/2009CN101397270A Polymorphic substance of donepezil salt, preparation and use thereof
03/2009
03/31/2009US7511159 Azetidine ring compounds and drugs comprising the same
03/31/2009US7511147 Process for manufacturing of chiral lobelin
03/31/2009US7511146 2-substituted benzimidazole piperidines analogs as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders
03/31/2009US7511144 Reverse hydroxamic acid derivatives
03/31/2009US7511141 Piperidine-piperazine ligands for neurotransmitter receptors
03/26/2009WO2009039461A2 N-substituted piperidine derivatives as serotonin receptor agents
03/26/2009WO2009037394A2 6-cycloamino-s-(pyridazin-4-yl)imidazo[1,2-b]-pyridazine and derivatives thereof preparation and therapeutic application thereof
03/26/2009WO2009009793A3 Inhibitors of akt/pkb with anti-tumor activity
03/26/2009WO2008144326A3 Synthesis of n-(4-fluorobenzyl)-n-(l-methylpiperidin-4-yl)-n'-(4- (2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline forms
03/26/2009US20090082408 Novel heterocyclic derivatives
03/26/2009US20090082399 Carbamate derivatives as positive allosteric modulators of metabotropic glutamate receptors
03/26/2009US20090082398 Crystalline forms of fexofenadine hydrochloride and processes for their preparation
03/26/2009US20090082397 anticholinergic agents such as biphenyl-2-ylcarbamic Acid 1-{2-[5-(4-Carbamoylpiperidin-1-yl)pentylcarbamoyl]ethyl}piperidin-4-yl ester, used for the treatment of respiratory system disorders such as chronic obstructive pulmonary disease and asthma; side effect reduction
03/26/2009US20090082350 Soluble epoxide hydrolase inhibitors
03/26/2009US20090082342 N-substituted piperidine derivatives as serotonin receptor agents
03/26/2009US20090082328 Substituted phenylamino-benzene derivatives useful for treating hyper-proliferative disorders and diseases associated with mitogen extracellular kinase activity
03/26/2009US20090082203 Insecticidal bis(substituted phenyl)-1-{[4-(saturated heterocyclyl-substituted)phenylmethyl]- (4-piperidyl)}methane derivatives
03/26/2009US20090080074 Polymer film, polarizing plate protective film, polarizing plate and liquid crystal display device
03/26/2009CA2700332A1 N-substituted piperidine derivatives as serotonin receptor agents
03/26/2009CA2693116A1 6-cycloamino-s-(pyridazin-4-yl)imidazo[1,2-b]-pyridazine and derivatives thereof preparation and therapeutic application thereof
03/25/2009EP2039681A1 Cycloalkene derivatives, process for production of the derivatives, and use of the same
03/25/2009EP2039349A1 Solid pharmaceutical composition comprising donepezil hydrochloride
03/25/2009EP2038453A2 Aqueous alkaline bath, devoid of cyanide, for the deposition of electroplated zinc and zinc alloy coatings
03/25/2009EP2038255A2 Pharmaceutical use of substituted piperidine carboxamides
03/25/2009EP2037918A2 Pharmaceutical formulations of pimavanserin
03/25/2009EP1756063A4 Amido compounds and their use as pharmaceuticals
03/25/2009CN101394831A Synthesis of a novel nitroxide antioxidant and methods of use in cosmetic and dermatological compositions
03/25/2009CN100471856C Bicyclic compounds and compostions as PDF inhibitors
03/24/2009US7507830 Process for preparing unsymmetrical biaryls and alkylated aromatic compounds from arylnitriles
03/24/2009US7507767 Sulfonamide-containing benzene derivatives which exhibit anti-inflammatory and immunodulatory activity
03/24/2009US7507753 Biaryl compound and use thereof
03/24/2009US7507751 Biphenyl derivatives
03/19/2009WO2009034582A2 Process for the preparation of amorphous fexofenadine hydrochloride
03/19/2009WO2009034380A1 Piperidine derivatives as agonists of muscarinic receptors
03/19/2009WO2009033995A1 Piperidine derivatives as nk3 receptor antagonists
03/19/2009WO2009033689A1 Piperidone derivatives and medical uses thereof
03/19/2009WO2009013299A3 Novel bradykinin b1 antagonists
03/19/2009WO2008131946A3 Substituted amide derivatives
03/19/2009US20090076083 Deuterium-enriched saredutant
03/19/2009US20090076082 Deuterium-enriched alvimopan
03/19/2009US20090076081 Piperidine derivatives as nk3 antagonists
03/19/2009US20090076080 Deuterium-enriched fexofenadine
03/19/2009US20090076026 Bronchodilators; treating chronic obstructive pulmonary disease or asthma; long duration of action; reduced side effects of dry-mouth and constipation; biphenyl carbamate derivatives; biphenyl-2-ylcarbamic acid 1-(3-(3-[3-(4-hydroxybenzylamino)propyl]-2-oxoimidazolidin-1-yl)propyl)piperidin-4-yl ester
03/19/2009US20090075975 Arylsulfonamides and uses related thereto
03/19/2009US20090074746 Compounds to treat alzheimer's disease
03/19/2009US20090074709 Methods, devices and systems for biocidal surface activity
03/19/2009CA2699464A1 Piperidine derivatives as nk3 receptor antagonists
03/19/2009CA2699286A1 Piperidine derivatives as agonists of muscarinic receptors
03/18/2009EP2036890A1 Crystalline form (i) of lercanidipine hydrochloride
03/18/2009EP2036556A1 Piperidone derivatives and medical uses thereof
03/18/2009EP2035401A2 Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics
03/18/2009EP2035382A1 Process for the preparation of sterically hindered nitroxyl ethers
03/18/2009EP2035381A1 Process for the preparation of sterically hindered nitroxyl ethers
03/18/2009EP2035380A2 Parp inhibitors
03/18/2009EP2035371A2 Substituted phenyl methanone derivatives
03/18/2009EP2000137A9 Triglyceride-lowering agent and hyperinsulinism-ameliorating agent
03/18/2009EP2000125A9 Hair dyeing composition
03/18/2009EP1567493B1 Phenyl substituted piperidine compounds for use as ppar activators
03/18/2009EP1546103B1 Piperazine and piperidine derivatives for treatment of neurological diseases
03/18/2009CN101389617A Novel processes for the preparation of piperazinyl and diazapanyl benzamide derivatives
03/18/2009CN100469776C Amelioration of the development of cataracts and other ophthalmic diseases
03/18/2009CN100469767C Bipiperidinyl-derivatives and their use as chemokine receptor inhibitors
03/17/2009US7504512 BCL-X1 protein inhibitors; anticarcinogenic agents
03/17/2009US7504511 e.g. N-[4-(5-Butyl-2-methoxyphenyl)-1,3-thiazol-2-yl]-4((4-[2-(S)-(hydroxymethyl)pyrrolidin-1-yl]piperidin-1-yl)carbonyl)benzamide; antiinflammatory, anticarcinogenic, antidiabetic, analgesic agent
03/17/2009US7504510 for protecting organic materials, in particular synthetic polymers, against oxidative, thermal, dynamic, light-induced and/or ozone-induced degradation
03/17/2009US7504432 Quaternary salt of (3-((2-(3,3-difluorocyclopentyl)-2-hydroxy-2-(4-methylphenyl)ethanoyl)oxy)-1,1-dimethylpyrrolidinium bromide; respiratory system disorders; chronic obstructive pulmonary diseases, bronchitis, asthma, emphysema, rhinitis; side effect reduction; inhalants; muscarinic receptor antagonists
03/17/2009US7504425 Compounds useful in the treatment of anthrax and inhibiting lethal factor
03/17/2009US7504419 Diastereomers of 4-aryloxy-3-hydroxypiperidines
03/17/2009US7504417 Substituted benzene derivatives or salts thereof
1 ... 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 ... 380